1. Home
  2. WST vs ERIC Comparison

WST vs ERIC Comparison

Compare WST & ERIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • ERIC
  • Stock Information
  • Founded
  • WST 1923
  • ERIC 1876
  • Country
  • WST United States
  • ERIC Sweden
  • Employees
  • WST N/A
  • ERIC N/A
  • Industry
  • WST Medical/Dental Instruments
  • ERIC Radio And Television Broadcasting And Communications Equipment
  • Sector
  • WST Health Care
  • ERIC Technology
  • Exchange
  • WST Nasdaq
  • ERIC Nasdaq
  • Market Cap
  • WST 20.1B
  • ERIC 31.7B
  • IPO Year
  • WST N/A
  • ERIC N/A
  • Fundamental
  • Price
  • WST $306.39
  • ERIC $9.48
  • Analyst Decision
  • WST Strong Buy
  • ERIC Hold
  • Analyst Count
  • WST 8
  • ERIC 1
  • Target Price
  • WST $339.43
  • ERIC $9.80
  • AVG Volume (30 Days)
  • WST 695.6K
  • ERIC 18.2M
  • Earning Date
  • WST 10-23-2025
  • ERIC 10-14-2025
  • Dividend Yield
  • WST 0.29%
  • ERIC 2.06%
  • EPS Growth
  • WST N/A
  • ERIC N/A
  • EPS
  • WST 6.68
  • ERIC 0.78
  • Revenue
  • WST $2,960,200,000.00
  • ERIC $25,502,929,121.00
  • Revenue This Year
  • WST $6.49
  • ERIC N/A
  • Revenue Next Year
  • WST $6.23
  • ERIC $0.71
  • P/E Ratio
  • WST $45.96
  • ERIC $12.18
  • Revenue Growth
  • WST 2.90
  • ERIC N/A
  • 52 Week Low
  • WST $187.43
  • ERIC $6.64
  • 52 Week High
  • WST $352.33
  • ERIC $9.87
  • Technical
  • Relative Strength Index (RSI)
  • WST 80.65
  • ERIC 68.44
  • Support Level
  • WST $260.12
  • ERIC $9.38
  • Resistance Level
  • WST $265.66
  • ERIC $9.64
  • Average True Range (ATR)
  • WST 6.80
  • ERIC 0.19
  • MACD
  • WST 2.75
  • ERIC 0.07
  • Stochastic Oscillator
  • WST 75.40
  • ERIC 77.72

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About ERIC Ericsson

Ericsson provides telecom equipment and services that are primarily used to build and operate mobile networks. The firm divides its business into three segments: networks, cloud and software services, and enterprise. Wireless carriers have traditionally been the firm's primary customers, but it is pushing to cater more to enterprises as well, as both try to take advantage of 5G capabilities and utilize "as-a-service" communications platforms. The company also licenses its patents to handset manufacturers.

Share on Social Networks: